Effects of Energy and Physical Density Manipulation on Appetite
NCT ID: NCT05408390
Last Updated: 2023-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2022-07-05
2023-05-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Effects of Energy Density and Eating Rate on Appetite
NCT01406886
Resistance Training and Appetite Regulation
NCT03985787
The Influence of Energy Density and Information on Meal Intake in Adults
NCT04404998
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
NCT00739362
The Effects of Energy Imbalance on Food Intake Behaviors
NCT03112161
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low physical and energy density
LPD+LED
Low physical density (LPD) + low energy density (LED) foods. Participants receive breakfast, lunch and snack items engineered to have LPD and LED.
High physical and low energy density
HPD+LED
High physical density (HPD) + low energy density (LED) foods. Participants receive breakfast, lunch and snack items engineered to have HPD and LED.
Low physical and high energy density
LPD+HED
Low physical density (LPD) + high energy density (HED) foods. Participants receive breakfast, lunch and snack items engineered to have LPD and HED.
High physical and energy density
HPD+HED
High physical density (HPD) + high energy density (HED) foods. Participants receive breakfast, lunch and snack items engineered to have HPD and HED.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LPD+LED
Low physical density (LPD) + low energy density (LED) foods. Participants receive breakfast, lunch and snack items engineered to have LPD and LED.
HPD+LED
High physical density (HPD) + low energy density (LED) foods. Participants receive breakfast, lunch and snack items engineered to have HPD and LED.
LPD+HED
Low physical density (LPD) + high energy density (HED) foods. Participants receive breakfast, lunch and snack items engineered to have LPD and HED.
HPD+HED
High physical density (HPD) + high energy density (HED) foods. Participants receive breakfast, lunch and snack items engineered to have HPD and HED.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to abstain from alcohol for 24 hours prior to and during days 1-2 of each study phase.
* Willing to abstain from strenuous exercise for 24 hours prior to and during days 1-2 of each study phase.
* Willing to abstain from a vegetarian/vegan diet or other highly restrictive diet (e.g., ketogenic diet, very high protein diet, Paleo diet) for two weeks prior to and throughout the study.
* Willing to maintain body weight throughout study.
* Willing to maintain usual diet (if not a restrictive diet), physical activity (aside from strenuous exercise limitation for 24 hours prior to and days 1-2 of each study phase) and nicotine use throughout study.
* Willing to abstain from dietary supplements (e.g., metabolism boosters, appetite suppressants, weight loss aids) impacting appetite or metabolism (as determined by study PI) throughout the study.
* Eats 3 meals per day at least 5 days/wk
Exclusion Criteria
* Taking prescription medications, other than a contraceptive, known to affect appetite, digestion and/or metabolism (e.g., anti-diabetic agents) (unless approved by study PI)
* Any chronic medical condition that limits food intake or alters metabolism, appetite or digestive physiology (e.g., gastric bypass, gastrointestinal disease, dysphagia, diabetes).
* Allergies and intolerances (e.g. gluten, dairy, nuts), unwillingness or inability to eat provided foods and beverages.
* Score of ≥13 on the restraint scale or ≥9 on the disinhibition scale of the Eating Inventory
* Weight gain or loss of \>5 lbs in the 2 weeks prior to study participation.
* Not willing or unable to adhere to all study procedures and restrictions.
17 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Army Research and Development Command- Soldier Center
UNKNOWN
United States Army Research Institute of Environmental Medicine
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J. Philip Karl
Role: PRINCIPAL_INVESTIGATOR
US Army Research Institute of Environmental Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
US Army Research Institute of Environmental Medicine
Natick, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M-10975
Identifier Type: OTHER
Identifier Source: secondary_id
22-03HC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.